0 items USD 0.00Search
Your search for "research global veljan tofacitinib drug market professional surveys 2018 manufacturing region" gave back 48768 results.
The “Tofacitinib Industry Forecast” looks at past sales and reviews total world Tofacitinib sales in 2022, providing a comprehensive analysis by...
Catalog:
LPI
March 2023
Price: USD 3,660.00
The global Tyrosine Kinase JAK Inhibitors market size was valued at USD 31360 million in 2023 and is forecast to a readjusted size of USD 497670...
Catalog:
GIR
January 2024
Price: USD 3,480.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
LPI
February 2023
Price: USD 3,660.00
JAK inhibitor I is a JAK1/2/3 inhibitor that decreased cell proliferation in breast cancer cells, increased apoptosis in esophageal squamous cell...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Tofacitinib Citrate Tablets market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast...
Catalog:
GIR
July 2023
Price: USD 4,480.00
The global Tofacitinib Citrate Tablets market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with...
Catalog:
GIR
July 2023
Price: USD 3,480.00
Publisher' newest research report, the “Generic Tofacitinib Industry Forecast” looks at past sales and reviews total world Generic Tofacitinib...
Catalog:
LPI
January 2023
Price: USD 3,660.00
The global Tofacitinib Citrate Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a...
Catalog:
LPI
June 2023
Price: USD 3,660.00
According to our Publisher latest study, the global Generic Tofacitinib market size was valued at USD million in 2022 and is forecast to a readjusted...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Tyrosine Kinase JAK Inhibitors market size was valued at US$ 29820 million in 2023. With growing demand in downstream market, the Tyrosine...
Catalog:
LPI
January 2024
Price: USD 3,660.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
LPI
January 2023
Price: USD 3,660.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
LPI
February 2023
Price: USD 3,660.00
JAK inhibitors are increasingly being used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis because of its proven efficacy...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Janus kinase inhibitors, also known as JAK inhibitors or jakinibs, are a type of medication that functions by inhibiting the activity of one or more...
Catalog:
GIR
April 2023
Price: USD 3,480.00
Tofacitinib, sold under the brand Xeljanz among others, is a medication used to treat rheumatoid arthritis, psoriatic arthritis, and ulcerative...
Catalog:
GIR
January 2023
Price: USD 3,480.00
